SCHEMBL1258720

SCHEMBL1258720

CC(C)(C)OC(=O)NCCCCCCNC(=S)Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
MAPT P10636 3/20 0.53
KMT2A Q03164 4/20 0.52
TDP1 Q9NUW8 1/20 0.52
LMNA P02545 3/20 0.50
GAA P10253 3/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
POLB P06746 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
RAB9A P51151 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HTT P42858 3/20 0.49
MEN1 O00255 1/20 0.49
NPSR1 Q6W5P4 2/20 0.49
XBP1 P17861 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ABAT P80404 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4396662 0.99 KMT2A (0.54) ALDH1A1MAPTKMT2ATDP1LMNA
SCHEMBL4392250 0.96 KMT2A (0.54) ALDH1A1MAPTKMT2ALMNAGAA
SCHEMBL4401844 0.93 KMT2A (0.56) ALDH1A1MAPTKMT2ALMNAGAA
SCHEMBL5097622 0.87 ALDH1A1 (0.50) ALDH1A1MAPTKMT2ATDP1LMNA
SCHEMBL27891147 0.86 EPHX1 (0.65) ALDH1A1MAPTKMT2ATDP1LMNA
SCHEMBL5100819 0.86 ALDH1A1 (0.51) ALDH1A1MAPTKMT2ATDP1LMNA
SCHEMBL4837793 0.84 CA1 (0.63) CA1CA2
SCHEMBL21224591 0.83 TDP1 (0.58) KMT2ATDP1GAACA1CA2
SCHEMBL4402193 0.83 CYP17A1 (0.49) KMT2ATDP1LMNAGAACA1
SCHEMBL24413361 0.83 CA1 (0.65) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024883-A1 NOVEL BROAD SPECTRUM ANTIVIRAL AND ANTIMICROBIAL PEPTIDE MIMICS NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2025-02-06 WO disclosed
US-8252940-B2 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection UNIVERSITY OF WASHINGTON (US) 2012-08-28 US disclosed
US-20110039849-A1 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION UNIVERSITY OF WASHINGTON (US) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039849-A1 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION IRF3, GDI2, TLR5 ALDH1A1 4529/4885MAPT 4503/4885KMT2A 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.